Anemia Clinical Trials in Tianjin, Tianjin Municipality
13 recruitingTianjin, Tianjin Municipality, China
Showing 1–13 of 13 trials
Recruiting
Early Phase 1
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Chronic Lymphocytic Leukemia (CLL)B-cell Acute Lymphoblastic Leukemia (B-ALL)Autoimmune Hemolytic Anemia, AIHA+1 more
Grit Biotechnology28 enrolled2 locationsNCT07205315
Recruiting
Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS
Myelodysplastic SyndromesAplastic AnemiaAutoimmune Hemolytic Anemia+1 more
Institute of Hematology & Blood Diseases Hospital, China323 enrolled1 locationNCT07578675
Recruiting
National Longitudinal Cohort of Hematological Diseases
Acute Myeloid LeukemiaMultiple MyelomaMyelodysplastic Syndrome+14 more
Institute of Hematology & Blood Diseases Hospital, China2,300 enrolled1 locationNCT04645199
Recruiting
Not Applicable
A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
Renal Anemia of Chronic Kidney Disease
Guangdong Provincial People's Hospital96 enrolled24 locationsNCT07136792
Recruiting
Phase 1Phase 2
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Autoimmune Hemolytic AnemiaEvans SyndromeAutoimmune Cytopenia+1 more
Keymed Biosciences Co.Ltd158 enrolled3 locationsNCT07175493
Recruiting
Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia
Brain functionCAR-T Cell TherapyAutoimmune Hemolytic Anemia+1 more
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06921980
Recruiting
Reproductive and Mental Health of Patients With Aplastic Anemia
Aplastic AnemiaReproductive Health
Institute of Hematology & Blood Diseases Hospital, China600 enrolled1 locationNCT06936930
Recruiting
Phase 1
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
RelapseCAR-T Cell TherapyRefractory+1 more
Institute of Hematology & Blood Diseases Hospital, China15 enrolled1 locationNCT06622694
Recruiting
National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic AnemiaAutoimmune Hemolytic Anemia Mixed Type
Institute of Hematology & Blood Diseases Hospital, China9,999 enrolled1 locationNCT07019038
Recruiting
Phase 1
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
Autoimmune Hemolytic AnemiaCD19/BCMA CAR T-cellsUniversal Allogeneic CAR T-cells
Institute of Hematology & Blood Diseases Hospital, China15 enrolled1 locationNCT06733610
Recruiting
Phase 2
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Aplastic AnemiaTPO Receptor Agonists
Institute of Hematology & Blood Diseases Hospital, China48 enrolled1 locationNCT06613880
Recruiting
Phase 2
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Immunosuppressive therapySevere Aplastic AnemiaCyclophosphamide Reduced-dose
Institute of Hematology & Blood Diseases Hospital, China75 enrolled1 locationNCT06695741
Recruiting
Phase 2
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Severe Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06254560